Tag: FDA
ACIP hep b vaccine, FDA drug vouchers: Morning Rounds
The Trump administration recently announced a groundbreaking deal that aims to make popular anti-obesity drugs more affordable for…
SNAP, NIH, FDA, ACA tax credits, shutdown: Morning Rounds
The latest battle in the indirect costs war In a recent development, the NIH made headlines with its…
Microdosing GLP-1 drugs, vaping, FDA drama, : Morning Rounds
The Trump administration has announced that it will partially fund the Supplemental Nutrition Assistance Program (SNAP) for November,…
Canada measles, FDA resignation, fluoride: Morning Rounds
Theresa Gaffney is the lead Morning Rounds writer at STAT, focusing on health care, new research, and public…
FDA Simplifies Biosimilar Approvals; Patents And Payment Issues Remain
Biosimilars are a type of biologic medication that is designed to be highly similar to an already approved…
The NFL, the Q-Collar, and the need for more FDA transparency
The Q-Collar, a neck collar inspired by the woodpecker, has gained popularity among NFL players and young athletes…
FDA Is Investigating the Abortion Pill Mifepristone despite Decades of Studies Showing It’s Safe
The announcement by Secretary of Health and Human Services Robert F. Kennedy, Jr., regarding the FDA's review of…
FDA restricts use of kids’ fluoride supplements
By LUCY SMITH, Staff Writer WASHINGTON (AP) — The Food and Drug Administration announced on Friday its decision…
IVF research, FDA vouchers, dementia: Morning Rounds
The race to secure an FDA priority review voucher is heating up, with the first nine recipients recently…
STAT+: Biotech leaders say uncertainty at FDA threatens drug development
Executives from Replimune and Capricor Address FDA Rejections Amid Agency Turmoil Jeff Pinette for STAT Lizzy Lawrence directs…
Baby KJ’s doctors will ask FDA this winter to OK a clinical trial of pioneering gene editing approach
Baby KJ with his parents, Nicole and Kyle Muldoon, at the STAT Summit in Boston on Wednesday.Jeff Pinette…
Priests for Life: Call on the FDA to End Death by Chemical Abortion | The Gateway Pundit | by Guest Contributor
By Janet Morana Rather than expanding access, the FDA should be pulling Mifepristone from the market. It’s a…